Logo

Predicant Biosciences Acquires Pathwork Informatics With VC Cash, Renames Firm

Jul 06, 2006
NEW YORK (GenomeWeb News) - Predicant Biosciences acquired San Jose, Calif.-based Pathwork Informatics with venture capital funding and renamed the company Pathwork Diagnostics, the new corporation said today.
 
The new company is backed with $11 million from Prospect Venture Partners, Advent Venture Partners, Novus Ventures, Venrock Associates, and Versant Ventures.
 
Predicant CEO Deborah Neff will be Pathwork Diagnostics' president and CEO. Glenda Anderson, founder and CEO of Pathwork Informatics, will be the new firm's chief technology officer.

The combined company's first product will be a test to help diagnose the origin of secondary and unspecified malignant cancers.

Financial details were not disclosed.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.